MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI in patients with MG (n=11) ...

Investigational pill was well-tolerated and doesn't come with food or water restrictions ...

Check out the top 10 sweepstakes casinos this month and see which platforms stand out for games, bonuses, and redemption in ...

The WIAA baseball postseason begins May 28 and these five teams from Manitowoc and Sheboygan have the best path to reach the ...

APEX Part B met all primary and secondary endpoints with high statistical significance; mid-dose zumilokibart planned to advance into Phase 3 ...

Declined 21.9% year over year to approximately $7.3 million, driven by reductions in payroll ($1.1 million), general and ...

New data show the benefits of orforglipron, the first oral, small molecule, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) to successfully complete a phase 3 program, for blood ...

The 240 mg dose of BGB-43395 plus letrozole resulted in a confirmed overall response rate (ORR) of 68.4% (95% CI: 43.4–87.4) and unconfirmed ORR of 73.7% (95% CI: 48.8-90.9).

Regeneron's EYLEA HD US sales surged 52% in Q1 2026, offsetting competitive pressures and patient switching within the EYLEA ...

Lasagna Dinner at Ss. Peter & Paul Ukrainian Catholic Church school hall, corner of North River and West Chestnut streets, ...

Battery & Energy Products Gross Margin -- 21.2%, down from 24.7%, negatively affected by plant shutdowns and severe weather.

Ralinepag works by restoring prostacyclin signaling and activating prostacyclin receptors to affect pathways that play a role in the progression of PAH. The drug was originally formulated as an ...